Article Information
PubMed
Published By
History
- Received January 9, 2019
- Revision received April 19, 2020
- Accepted May 5, 2020
- Published online July 31, 2020.
Copyright & Usage
Copyright © 2020 Torero Ibad et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Raoul Torero Ibad1,*,
- Bilal Mazhar1,*,
- Clémentine Vincent1,*,
- Clémence Bernard1,
- Julie Dégardin2,
- Manuel Simonutti2,
- Thomas Lamonerie3,
- Ariel A. Di Nardo1,
- Alain Prochiantz1,4,5 and
- Kenneth L. Moya1
- 1Centre for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, UMR 7241, INSERM U1050, Labex MemoLife, Université PSL (Paris Sciences & Lettres), 75005 Paris, France
- 2CNRS, INSERM, Institut de la Vision, Sorbonne Université, F-75012 Paris, France
- 3CNRS, INSERM, Institut de Biologie Valrose, Université Côte d’Azur, 06088 Nice, France
- 4BrainEver, 75012 Paris, France
- 5Institute of Neurosciences, Chinese Academy of Sciences, Shanghai 200031, People’s Republic of China
- Correspondence should be addressed to Kenneth L. Moya at ken.moya{at}college-de-france.fr.
Author contributions
Author contributions: R.T.I., T.L., A.A.D., A.P., and K.L.M. designed research; R.T.I., B.M., C.V., C.B., J.D., and M.S. performed research; R.T.I., C.V., C.B., and K.L.M. analyzed data; R.T.I., A.A.D., A.P., and K.L.M. wrote the paper.
↵* R.T.I., B.M., and C.V. contributed equally to this work. [fn_type;equal]
Disclosures
K.L.M. and A.P. are listed on patents for the use of homeoproteins to treat neurodegenerative disease, and each holds equity in a startup company with that aim. The authors declare no other competing financial interests.
This research was supported by grants HOMEOSIGN (Grant ERC-2013-AdG 339379) and NeuroprOtx (Grant ANR-16-CE16-0003-02).
Funding
European Research Commission
ERC-2013-AdG n{°}339379Agence National pour la Recherche
NeuroprOtx : ANR-16-CE16-0003-02
Other Version
- You are viewing the most recent version of this article.
- previous version (July 31, 2020).